SLC10A2
MOLECULAR TARGETsolute carrier family 10 member 2
SLC10A2 (solute carrier family 10 member 2) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting SLC10A2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Deoxycholic Acid | 1.10 | 2 |
| 2 | Chenodeoxycholic Acid | 0.69 | 1 |
| 3 | Glycochenodeoxycholic Acid | 0.69 | 1 |
| 4 | Glycodeoxycholic Acid | 0.69 | 1 |
| 5 | Taurochenodeoxycholic Acid | 0.69 | 1 |
| 6 | Taurocholic Acid | 0.69 | 1 |
About SLC10A2 as a Drug Target
SLC10A2 (solute carrier family 10 member 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented SLC10A2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
SLC10A2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.